No Data
No Data
Piper Sandler Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Cuts Target Price to $40
Piper Sandler Remains a Hold on Apellis Pharmaceuticals (APLS)
Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
Wells Fargo Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Cuts Target Price to $43
CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Monday
Baird Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Cuts Target Price to $92
No Data
No Data
EZ_money OP : majority at buy rating
102327823 : india confirmed first case of mpox clade 1b
EZ_money OP 102327823 : interesting